This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Uncomplicated Urogenital Gonorrhea
and you are
over 19
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

To determine the safety and efficacy of a single dose of solithromycin (CEM-101) for the treatment of uncomplicated urogenital gonorrhea.

Provided treatments

  • Drug: solithromycin
  • Drug: Solithromycin (CEM-101)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01591447. The sponsor of the trial is Melinta Therapeutics, Inc. and it is looking for 60 volunteers for the current phase.
Official trial title:
An Open-Label Study to Evaluate the Efficacy and Safety of a Single-Dose of Oral CEM-101 in the Treatment of Male and Female Patients With Uncomplicated Urogenital Gonorrhea